Stockreport

Pharvaris Presents Data at the Bradykinin Symposium 2024 [Yahoo! Finance]

Pharvaris N.V. - Ordinary Shares  (PHVS) 
PDF B2 receptor antagonists to prevent and treat hereditary angioedema (HAE) attacks, today announced a summary of data being presented at the ongoing 7th Bradykinin Symposi [Read more]